Opus Genetics (IRD) Cash from Investing Activities Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 63.81% |
| Dec 31, 2021 | -15.11% |
| Dec 31, 2020 | 16.28% |
| Dec 31, 2019 | 43.95% |
| Sep 30, 2019 | 16.50% |
| Jun 30, 2019 | 109.08% |
| Mar 31, 2019 | -190.39% |
| Dec 31, 2018 | 45.25% |
| Sep 30, 2018 | 200.92% |
| Jun 30, 2018 | 53.02% |
| Mar 31, 2018 | 86.18% |
| Dec 31, 2017 | -28.49% |
| Sep 30, 2017 | 40.53% |
| Jun 30, 2017 | -44.23% |
| Mar 31, 2017 | 35.39% |
| Dec 31, 2016 | 25.48% |
| Sep 30, 2016 | -59.60% |
| Jun 30, 2016 | 29.53% |
| Mar 31, 2016 | 23.67% |
| Dec 31, 2015 | -31.94% |
| Sep 30, 2015 | 81.29% |